Lataa...
The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects
Biologic therapies have revolutionized treatment of a number of diseases. Patents and exclusivity for a number of biologics are expiring. This has created the opportunity for the development and approval of biosimilars. Biosimilars are biologic products developed using a step-wise approach to result...
Tallennettuna:
| Julkaisussa: | Drugs |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer International Publishing
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5375962/ https://ncbi.nlm.nih.gov/pubmed/28258517 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-017-0717-1 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|